Cargando…
Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic
Autores principales: | Neeraja, Koti, Surisetti, Bharath Kumar, Mol, Nisha, Prasad, Shweta, Holla, Vikram Venkappayya, Kamble, Nitish, Mahale, Rohan, Pal, Pramod Kumar, Yadav, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965966/ https://www.ncbi.nlm.nih.gov/pubmed/35359564 http://dx.doi.org/10.4103/aian.AIAN_573_20 |
Ejemplares similares
-
Clinical and Imaging Profile of Patients with Joubert Syndrome
por: Surisetti, Bharath Kumar, et al.
Publicado: (2021) -
Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis
por: Holla, Vikram Venkappayya, et al.
Publicado: (2020) -
Sialidosis Type I without a Cherry Red Spot— Is There a Genetic Basis?
por: Neeraja, Koti, et al.
Publicado: (2021) -
Patient Knowledge, Attitude and Perceptions towards Botulinum Toxin Treatment for Movement Disorders in India
por: Mol, Thavasimuthu Nisha, et al.
Publicado: (2021) -
Movement Disorders Associated With Radiotherapy and Surgical Procedures
por: Surisetti, Bharath Kumar, et al.
Publicado: (2023)